<DOC>
	<DOCNO>NCT02028130</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) affect many 1 16 people age 65 reduces quality life large number people UK around world . Catheter ablation minimally invasive treatment develop help eliminate AF . Recent study identify particular area heart , namely leave atrial appendage ( LAA ) , pouch leave atrium ( small collect chamber heart ) , may main source AF many case . There clear lack knowledge structure , anatomy , function electrical property LAA , fundamental further understanding management AF . In addition , well know AF significantly increase risk stroke . The majority stroke occur due blood clot form LAA . Traditionally , effective treatment minimise risk stroke thin blood agent warfarin . This therapy require regular blood test much inconvenience patient increase risk bleed complication . Recently , large study demonstrate use implanted device ( Watchman® ) occlude LAA effective warfarin prevent stroke confers low mortality rate . We aim investigate whether safe feasible ablate LAA implant Watchman® device procedure patient atrial fibrillation time .</brief_summary>
	<brief_title>Left Atrial Appendage Electrical Isolation Occlusion Treat Persistent Atrial Fibrillation : A Safety Feasibility Study</brief_title>
	<detailed_description>While catheter ablation revolutionize treatment atrial fibrillation ( AF ) , long-term outcome treat persistent AF variable , often require one procedure maintain long-term freedom AF . Electrical isolation pulmonary vein ( PVs ) central catheter ablation strategy , majority paroxysmal AF recurrence associate reconnection previously isolate PVs . Persistent AF different , recurrence attributable foci substrate outside PVs , include leave atrial appendage ( LAA ) . Recently , non-randomised , consecutive study 987 patient undergoing repeat catheter ablation persistent ( 82 % ) paroxysmal ( 18 % ) AF demonstrate almost 30 % recurrence due LAA focus addition LAA electrical isolation standard persistent AF ablation strategy improve freedom AF . Percutaneous LAA occlusion demonstrate effective warfarin reduce risk thromboembolic stroke patient AF . The combination standard AF ablation lesion set LAA electrical isolation LAA occlusion may elegant method improve success rate ablation persistent AF whilst also mitigate stroke risk reduce bleed risk long-term anticoagulation . However , feasibility safety concomitant endocardial electrical isolation mechanical occlusion LAA know . In study test hypothesis concomitant electrical isolation LAA occlusion Watchman device , follow standard persistent AF lesion set feasible safe .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Age 18 80 year Symptomatic , documented AF last least 7 day ( persistent permanent AF ) refractory least 1 AAD and/or DCCV Longterm indication continue warfarin Previous ablation procedure Pregnancy Prior AV nodal ablation complete heart block ( CHB ) permanent pacemaker ( PPM ) Contraindication anticoagulation Persistent thrombus leave atrium despite anticoagulation Active malignancy Expected life expectancy &lt; 6 month Cerebrovascular accident within previous 6 month Reversible cause AF include thyroid disorder , acute alcohol intoxication , recent major surgical procedure , trauma Cardiac event include myocardial infarction ( MI ) , percutaneous coronary intervention ( PCI ) , valve coronary bypass surgery within previous 3 month Prior leave atrial catheter ablation intention treat AF Prior surgical intervention AF MAZE procedure Previous heart transplant Severe neuro−muscular disease Creatinine clearance &lt; 30 ml/min ( estimate GFR ) Current participation another research study Unable understand comply protocol give write informed consent Contraindication general anaesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Ablation</keyword>
	<keyword>Left atrial appendage occlusion</keyword>
	<keyword>Stroke prevention</keyword>
</DOC>